ReviewAsia-Pacific journal of oncology nursing2026
Best evidence for the prevention and management of anastomotic fistula after esophagectomy in patients with esophageal cancer.
Review in Asia-Pacific journal of oncology nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Anastomotic fistula is a common complication in patients with esophageal cancer following surgery. It leads to delayed healing, malnutrition, reduced quality of life, and increased patient pain and medical costs. Preventing anastomotic fistula can significantly enhance patients' quality of life. This study aimed to summarize the best evidence for the prevention and management of anastomotic fistula after esophagectomy in patients with esophageal cancer, providing a reference for clinical nursing practice. Methods: Following the '6S' evidence resource model, evidence retrieval was conducted from the top-down, collecting clinical practice guidelines, systematic evaluations, meta-analyses, and expert consensus. The retrieval period spanned from database inception to February 2026. Two reviewers independently screened and assessed the literature, subsequently extracting and summarizing the evidence according to the JBI system for grading evidence and recommendations. Results: A total of 11 articles were included: 3 guidelines, 6 systematic reviews, and 2 randomized controlled trials. A total of 19 best evidence were identified for the prevention and management of anastomotic fistula in postoperative patients with esophageal cancer. These pieces of evidence encompass key areas including monitoring and evaluation, fistula care, pipeline care, respiratory tract management, psychological care, nutrition management, drug management, complication management, and health education. Conclusions: This study summarized the best evidence for the prevention and management of anastomotic fistula after esophagectomy in patients with esophageal cancer, providing a reference for clinical nursing practice. The application of evidence should be tailored according to the department's clinical condition and individual patient circumstances. Systematic review registration: This study was registered at the Fudan University Centre for Evidence-based Nursing (Registration No. ES20244220).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.